Standard Surfactants Limited’s board of directors approved the unaudited financial results for the quarter ended June 30, 2026, during a meeting held on August 31, 2026. The session also saw the appointment of a new cost auditor for the upcoming fiscal year.

The board considered and accepted the limited review report on the financial results for the quarter. No dividend was declared during this meeting.

Corporate Actions

The company announced the convening of its 37th Annual General Meeting (AGM) scheduled for September 30, 2026. Key logistical details include:

• Scrutinizer: Mr. Shivansh Tiwari, Practicing Company Secretary, was appointed as the scrutinizer for postal ballot and electronic voting.
• Share Transfer Closure: The register of members and share transfer books will remain closed from September 25, 2026, to September 30, 2026, inclusive.
• Approvals: The draft notice for the AGM, along with the Directors’ Report and applicable annexures for the financial year ended March 31, 2026, were approved.

Auditor Appointment

The board appointed M/s Hammad Abbas & Co as the Cost Auditor for the Financial Year 2025-26. The firm, which has more than five years of experience, was appointed for a term of one year effective from August 31, 2026.

Standard Surfactants cancelled its board of directors meeting scheduled for Thursday, August 20, 2026. The meeting was originally convened to consider and approve the unaudited financial results for the quarter ended June 30, 2026 (Q1FY27). The cancellation occurred due to the non-availability of a quorum.

The company informed the Bombay Stock Exchange that it will issue a fresh intimation with the revised date for the board meeting in due course, as per regulatory requirements. This follows the initial intimation dated August 17, 2026.

Trading Window Status

The trading window for designated persons remains closed. It will stay closed until 48 hours after the board meeting held for the adoption of the June 30, 2026 results. Investors should note that no financial figures were released during this period as the meeting did not proceed.

What the Numbers Show

As the board meeting was cancelled, no financial data for Q1FY27 was disclosed. Consequently, there are no revenue, profit, or margin figures to analyze for this reporting period. The delay prevents immediate assessment of the company's operational performance for the first quarter of FY27.